OLMA OLEMA PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2025 - Equity Exchange Olema Pharmaceuticals has entered into agreements to exchange shares of its common stock for pre-funded warrants with Bain Capital, Paradigm BioCapital, and BVF Partners, totaling approximately 6,070,000 shares, expected to close on January 13, 2025, increasing the total outstanding shares to about 68,333,065.Get access to all SEC 8-K filings of the OLEMA PHARMACEUTICALS INC